JALDURZO Trademark

Trademark Overview


On Tuesday, April 9, 2019, a trademark application was filed for JALDURZO with the United States Patent and Trademark Office. The USPTO has given the JALDURZO trademark a serial number of 88377509. The federal status of this trademark filing is REGISTERED as of Tuesday, September 29, 2020. This trademark is owned by MorphoSys AG. The JALDURZO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as an ingredient of pharmaceuticals for the treatment of treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological pre...

research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development ser...
jaldurzo

General Information


Serial Number88377509
Word MarkJALDURZO
Filing DateTuesday, April 9, 2019
Status700 - REGISTERED
Status DateTuesday, September 29, 2020
Registration Number6161316
Registration DateTuesday, September 29, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 14, 2020

Trademark Statements


Goods and Servicespharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as an ingredient of pharmaceuticals for the treatment of treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
Goods and Servicesresearch and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 26, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameINCYTE HOLDINGS CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWILMINGTON, DE 19803

Party NameMorphoSys AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPlanegg 82152
DE

Party NameMorphoSys AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPlanegg 82152
DE

Party NameMorphoSys AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPlanegg 82152
DE

Trademark Events


Event DateEvent Description
Monday, May 6, 2019ASSIGNED TO LIE
Friday, April 12, 2019NEW APPLICATION ENTERED
Friday, April 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, April 28, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, May 7, 2019PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, June 19, 2019ASSIGNED TO EXAMINER
Wednesday, June 19, 2019NON-FINAL ACTION WRITTEN
Wednesday, June 19, 2019NON-FINAL ACTION E-MAILED
Wednesday, June 19, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 1, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 1, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 4, 2019FINAL REFUSAL WRITTEN
Wednesday, December 4, 2019FINAL REFUSAL E-MAILED
Wednesday, December 4, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, May 28, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, May 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 8, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, June 8, 2020EXAMINER'S AMENDMENT ENTERED
Monday, June 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 24, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 14, 2020PUBLISHED FOR OPPOSITION
Tuesday, July 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 29, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, April 24, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, May 1, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 17, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 17, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 8, 2020EXAMINERS AMENDMENT E-MAILED
Monday, June 8, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 29, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED